UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): OCTOBER 21, 2003
THE MEDICINES COMPANY
--------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
DELAWARE 000-31191 04-3324394
---------------------------- ---------------- ---------------------------
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
8 CAMPUS DRIVE
PARSIPPANY, NEW JERSEY 07054
---------------------------------------- ---------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (973) 656-1616
--------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
ITEM 12. DISCLOSURE OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On October 21, 2003, The Medicines Company (the "Company") announced its
financial results for the quarter ended September 30, 2003. The full text of the
press release issued in connection with the announcement is attached as Exhibit
99.1 to this Current Report on Form 8-K.
The information in this Current Report on Form 8-K and the Exhibit attached
hereto shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated by reference in
any filing under the Securities Act of 1933 or the Exchange Act, except as
expressly set forth by specific reference in such a filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
THE MEDICINES COMPANY
Date: October 21, 2003 By: /s/ Steven H. Koehler
--------------------------
Steven H. Koehler
Vice President and Chief Financial
Officer
EXHIBIT INDEX
Exhibit No. Description
----------- -----------
99.1 Press release dated October 21, 2003
entitled "The Medicines Company
Reports Third Quarter 2003 Financial
Results."